The Food and Drug Administration Feb. 5 released an alert notifying patients of a safety concern using diabetes devices such ...
IBD Aware, a wearable medical device in development for patients with inflammatory bowel disease, aims to improve disease ...
The U.S. Food and Drug Administration (FDA) has given its second most serious risk level, Class II, to a product from D. Coluccio & Sons. The recalled product is a 300 gram pack of chocolate chip ...
The FDA approved Datroway to treat metastatic or unresectable HR+/HER2- breast cancer in people who have tried standard chemo ...
Our experts explain the science behind red light therapy, and if it really works. Plus, we recommend some FDA-cleared wands ...
The U.S. Food and Drug Administration has approved Onapgo (apomorphine hydrochloride) injection as the first and only ...
The ACR-368-tailored OncoSignature assay is being used to identify patients most likely to respond to the company's lead drug candidate ACR-368 in an ongoing, registrational-intent, phase IIb trial in ...
Acrivon Therapeutics said the Food and Drug Administration has granted Breakthrough Device designation for its ACR-368 OncoSignature assay, an immunofluorescence assay for the identification of ...
Genentech, a member of the Roche Group (SIX: RO, ROG; OTCQX: RHHBY) announced today that the U.S. Food and Drug ...
The FDA approved an apomorphine hydrochloride infusion device (Onapgo) to treat motor fluctuations in adults with advanced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback